Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.160
-0.040 (-1.82%)
Jan 30, 2026, 9:58 AM EST - Market open
Neuronetics Employees
Neuronetics had 716 employees as of December 31, 2024. The number of employees increased by 513 or 252.71% compared to the previous year.
Employees
716
Change
513
Growth
252.71%
Revenue / Employee
$181,387
Profits / Employee
-$62,154
Market Cap
147.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 716 | 513 | 252.71% |
| Sep 30, 2024 | 201 | -10 | -4.74% |
| Jun 30, 2024 | 203 | -6 | -2.87% |
| Mar 31, 2024 | 202 | 2 | 1.00% |
| Dec 31, 2023 | 203 | 9 | 4.64% |
| Sep 30, 2023 | 211 | 13 | 6.57% |
| Jun 30, 2023 | 209 | 25 | 13.59% |
| Mar 31, 2023 | 200 | 13 | 6.95% |
| Dec 31, 2022 | 194 | 19 | 10.86% |
| Sep 30, 2022 | 198 | 33 | 20.00% |
| Jun 30, 2022 | 184 | 23 | 14.29% |
| Mar 31, 2022 | 187 | 40 | 27.21% |
| Dec 31, 2021 | 175 | 49 | 38.89% |
| Sep 30, 2021 | 165 | 43 | 35.25% |
| Jun 30, 2021 | 161 | 47 | 41.23% |
| Mar 31, 2021 | 147 | 30 | 25.64% |
| Dec 31, 2020 | 126 | -109 | -46.38% |
| Sep 30, 2020 | 122 | -113 | -48.09% |
| Jun 30, 2020 | 114 | - | - |
| Mar 31, 2020 | 117 | -74 | -38.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Inogen | 766 |
| InfuSystem Holdings | 514 |
| Treace Medical Concepts | 477 |
| AVITA Medical | 260 |
| Apyx Medical | 220 |
| CVRx, Inc. | 206 |
| Rapid Micro Biosystems | 163 |
| LENSAR | 140 |
STIM News
- 2 months ago - Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - Benzinga
- 2 months ago - TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression - GlobeNewsWire
- 3 months ago - Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan - GlobeNewsWire
- 3 months ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence - GlobeNewsWire
- 3 months ago - Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call - GlobeNewsWire